FDA Approves Medtronic AdaptiveStim Neurostimulator

The FDA approved Medtronic’s AdaptiveStim with the RestoreSensor neurostimulation system, according to a Medtronic news release.

Advertisement

The system uses motion sensor technology to automatically adapt stimulation levels to the needs of people with chronic back and leg pain. It also recognizes and remembers the correlation between a change in body position — as a person is standing, sitting or laying down — and stimulation level and will automatically adjust the level based on body position. It also records the frequency of posture changes.

Related Articles on Pain Management:
Researchers Find Success With Mind-Body Techniques for Reducing Pain
Sleep Problems Triple Women’s Fibromyalgia Risk
Study: Oncologists Score Low on Pain Management

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.